Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov.

Publikation

Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov.

Wissenschaftlicher Artikel/Review - 23.03.2023

Ukegjini Kristjan, Guidi Marisa, Lehmann Kuno, Süveg Krisztian, Putora Paul Martin, Cihoric Nikola, Steffen Thomas

Zitation

Ukegjini K, Guidi M, Lehmann K, Süveg K, Putora P, Cihoric N, Steffen T. Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov. Cancers (Basel) 2023; 15

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Cancers (Basel) 2023; 15

Veröffentlichungsdatum

23.03.2023

ISSN (Druck)

2072-6694

Kurzbeschreibung/Zielsetzung

Over the past two decades, cytoreductive surgery and HIPEC has improved outcomes for selected patients with peritoneal metastasis from various origins. This is a cross-sectional study with descriptive analyses of HIPEC trials registered on ClinicalTrials.gov. This study aimed to characterize clinical trials on HIPEC registered on ClinicalTrials.gov with the primary objective of identifying a trial focus and to examine whether trial results were published.